DNA synthesis inhibitors: Metronidazole

20,665views

DNA synthesis inhibitors: Metronidazole

Family Medicine (Clinical Year)

Family Medicine (Clinical Year)

Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Peripheral vascular disease: Clinical
Leg ulcers: Clinical
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Antiplatelet medications
Hypersensitivity skin reactions: Clinical
Eczematous rashes: Clinical
Papulosquamous skin disorders: Clinical
Alopecia: Clinical
Hypopigmentation skin disorders: Clinical
Benign hyperpigmented skin lesions: Clinical
Skin cancer: Clinical
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Dizziness and vertigo: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Diarrhea: Clinical
Malabsorption: Clinical
Colorectal cancer: Clinical
Diverticular disease: Clinical
Anal conditions: Clinical
Cirrhosis: Clinical
Breast cancer: Clinical
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Anemia: Clinical
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Lymphoma: Clinical
Thrombocytopenia: Clinical
Leukemia: Clinical
Pneumonia: Clinical
Urinary tract infections: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anti-mite and louse medications
Chronic kidney disease: Clinical
Kidney stones: Clinical
Urinary incontinence: Pathology review
PDE5 inhibitors
Stroke: Clinical
Lower back pain: Clinical
Headaches: Clinical
Migraine medications
Seizures: Clinical
Hypokinetic movement disorders: Clinical
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Lung cancer: Clinical
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Joint pain: Clinical
Rheumatoid arthritis: Clinical
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Amenorrhea: Clinical
Contraception: Clinical
Virilization: Clinical
Infertility: Clinical
Vulvovaginitis: Clinical
Sexually transmitted infections: Clinical
Menopause
Abnormal uterine bleeding: Clinical
Cervical cancer: Clinical
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Benign breast conditions: Pathology review
Pediatric allergies: Clinical
Pediatric ear, nose, and throat conditions: Clinical
Pediatric constipation: Clinical
Pediatric gastrointestinal bleeding: Clinical
Pediatric vomiting: Clinical
Bowel obstruction: Clinical
Gallbladder disorders: Clinical
Appendicitis: Clinical
Gastrointestinal bleeding: Clinical
Pancreatitis: Clinical
Vaccinations: Clinical
Pediatric infectious rashes: Clinical
Skin and soft tissue infections: Clinical
Pediatric bone and joint infections: Clinical
Pediatric urological conditions: Clinical
Elimination disorders: Clinical
Neurodevelopmental disorders: Clinical
Pediatric ophthalmological conditions: Clinical
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
BRUE, ALTE, and SIDS: Clinical
Pediatric orthopedic conditions: Clinical
Mood disorders: Clinical
Anxiety disorders: Clinical
Eating disorders: Clinical
Obsessive compulsive disorders: Clinical
Personality disorders: Clinical
Sleep disorders: Clinical
Substance misuse and addiction: Clinical
Somatic symptom disorders: Clinical
Sexual dysfunctions: Clinical

Transcript

Watch video only

DNA synthesis inhibitors are a group of antibiotics that target the synthesis of DNA in bacteria and other organisms. Metronidazole, a 5-nitroimidazole, prevents the synthesis of nucleic acids, which are the building blocks of DNA, and is effective against many bacteria and protozoans.

Metronidazole and related 5-nitroimidazoles are relatively nontoxic to humans. This is because in order to function, they need to be reduced by a protein called ferredoxin, which contains sulfur and iron. This protein is commonly found in anaerobic bacteria and protozoans, but is not as available in humans and aerobic bacteria. Now, this protein can donate an electron to metronidazole, causing it to form free radicals which will damage the DNA, causing it to fragment. Without the DNA as a template, the organism can’t synthesize any more nucleic acids like DNA or mRNA, which will lead to cell death.

Metronidazole can be taken orally, but it’s also available in an IV form and as topical creams. It penetrates well into body tissues and fluids, including vaginal secretions, seminal fluid, saliva, breast milk, cerebrospinal fluid, and crosses over the placenta.

This medication can treat many anaerobic bacterial infections like Clostridioides difficile, which can cause pseudomembranous enterocolitis in people taking other antibiotics. Another common organism treated by this medication is Helicobacter pylori, a common bacteria that causes gastritis and peptic ulcers. However, it should be used in combination with other antimicrobials and proton pump inhibitors as part of a triple therapy for the best outcome when treating this condition. Next, Gardnerella vaginalis and other anaerobes that can cause bacterial vaginosis are all treated by metronidazole.

For protozoan infections, it’s the medication of choice for amoebiasis, an infection of the gut caused by Entamoeba histolytica. It’s the medication of choice against Trichomonas vaginalis as well, which causes vaginal trichomoniasis. Finally, metronidazole is highly effective against giardiasis, or beaver fever, which is an infection of the gut caused by Giardia lamblia.

Metronidazole is metabolized in the liver and it’s an inhibitor of CYP450 enzymes, so it can slow down the metabolism of other medications, like warfarin, which are also broken down by this enzyme.

Common side effects of metronidazole include decreased appetite, nausea, a metallic taste in the mouth, headaches, and stomach cramps.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review, 12th ed. © (ISBN-13: 978-1259641022) " Katzung (2018 )
  2. "Rang & Dale’s Pharmacology, 9th ed,. © (ISBN-13: 978-0702074486) " Ritter (2019 )
  3. "Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 13th ed. (ISBN-13: 978-1259584732 " Brunton
  4. "Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). 66(7), e1-e48. " Clinical Infectious Diseases (2018)
  5. "Bacterial Vaginosis: Review of Treatment Options and Potential Clinical Indications for Therapy. 28(s1), S57-S65. " Clinical Infectious Diseases (1999)
  6. "Sudden Death Due to Metronidazole/Ethanol Interaction. 17(4), 343-346." The American Journal of Forensic Medicine and Pathology (1996)
  7. "A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity. 45(3), 302-307. " Clinical Infectious Diseases (2007)
  8. "Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action. Journal of Antimicrobial 31(1), 9-20. " Chemotherapy (1993)